Life Sciences Company In-Licensing From Universities and Other Tax-Exempt Entities

Life sciences companies often employ in-licensing of academic institutions' and other tax-exempt entities' intellectual property (IP) to drive innovation further. In such deals, it is critically important that life sciences companies understand the IRS' guidance in this space and are equipped with the knowledge to negotiate favorable terms.

Join us for an insightful webinar providing a comprehensive overview of the policies guiding IP licensing as it relates to medical research, examining the tax implications that tax-exempt organizations must navigate, and diving into the key negotiation terms to ensure successful collaborations between life sciences companies and academic institutions and other tax-exempt organizations.

Our program will focus around four areas:

• Overview of tax-exempt organizations and tax implications of IP out-licensing by such organizations
• Motivations of universities and tax-exempt organizations in out-licensing
• University and other tax-exempt organizations' perspectives on out-licensing, including applicable laws, policies and practices, and critical licensing provisions that often cause contention in transactions with life sciences companies
• Life sciences industry perspective on university and tax-exempt deals

We invite you to join this interactive webinar with questions.